United Arab Emirates & Noura Khamis Al Ghaithi

United Arab Emirates: The United Arab Emirates has launched its first genomics-driven clinical trial, leveraging the Emirati Genome Program to advance precision medicine and establish itself as a global hub for biotechnology and research.

Noura Khamis Al Ghaithi: Dr. Noura Khamis Al Ghaithi, Undersecretary of the United Arab Emirates — Department of Health – Abu Dhabi, highlighted the initiative's role in using genomic data for earlier disease risk prediction and personalized healthcare.

United Arab Emirates: The United Arab Emirates accelerates investment in life sciences infrastructure, with Biosphere Labs representing a significant step in advancing healthcare and biotechnology innovation.

Noura Khamis Al Ghaithi: Noura Khamis Al Ghaithi, Undersecretary of the Department of Health - MGX, stated that Biosphere Labs strengthens the ecosystem by providing necessary infrastructure for scientific research.

United Arab Emirates: The United Arab Emirates (UAE) benefits from this collaboration through the advancement of its National Cancer Strategy and the development of a leading life science ecosystem in Abu Dhabi. This enhances the UAE's global standing in healthcare innovation.

Noura Khamis Al Ghaithi: H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health - Abu Dhabi (DoH), emphasized the population-level impact of this partnership, highlighting DoH's commitment to sustainable innovation.